Publication date: August 2019Source: Oral Oncology, Volume 95Author(s): Tian-Tian Zhai, Johannes A. Langendijk, Lisanne V. van Dijk, Gyorgy B. Halmos, Max J.H. Witjes, Sjoukje F. Oosting, Walter Noordzij, Nanna M. Sijtsema, Roel J.H.M. SteenbakkersAbstractObjectivesThe aim of this study was to investigate whether quantitative CT image-biomarkers (IBMs) can improve the prediction models with only classical prognostic factors for local-control (LC), regional-control (RC), distant metastasis-free survival...
Publication date: Available online 26 June 2019Source: Oral OncologyAuthor(s): Mathangi Kumar, Ravindranath Vineetha, Adarsh KudvaAbstractOsteonecrosis of the jaw is a potential side effect of certain pharmaceutical agents used in the field of medicine. Early diagnosis and effective management of this condition can be challenging to the clinicians. Bisphosphonates and other anti-angiogenic agents are the most common drugs that are attributed to cause medication-related osteonecrosis of the jaw. In...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου